C12Y 207/07006
Dna-directed rna polymerase
Official title: DNA-directed RNA polymerase (2.7.7.6)
C12Y207/07006 (Dna-directed rna polymerase) appears on 111 US grants and 216 published applications in this corpus.
Search patents in C12Y- Granted patents
- 111
- Published applications
- 216
- Assignees
- 120
- Inventors
- 534
- Latest grant
- 28 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 3 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 1 |
| 2004 | 1 | 2 |
| 2005 | 1 | 2 |
| 2006 | 0 | 1 |
| 2007 | 1 | 0 |
| 2008 | 0 | 1 |
| 2009 | 1 | 2 |
| 2010 | 1 | 1 |
| 2011 | 1 | 3 |
| 2012 | 1 | 2 |
| 2013 | 0 | 2 |
| 2014 | 0 | 1 |
| 2015 | 3 | 7 |
| 2016 | 2 | 16 |
| 2017 | 10 | 16 |
| 2018 | 6 | 7 |
| 2019 | 8 | 12 |
| 2020 | 8 | 18 |
| 2021 | 11 | 16 |
| 2022 | 11 | 21 |
| 2023 | 9 | 14 |
| 2024 | 13 | 25 |
| 2025 | 12 | 27 |
| 2026 | 7 | 19 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- RNA replication using transcription polymerases28 Apr 2026US 12,612,658 B2The Board of Trustees of the Leland Stanford Junior University
- Synthesis of transcripts using VSW-3 RNA polymerase14 Apr 2026US 12,600,957 B2RNAsyn Biotech. Co., Ltd.
- Methods and compositions for manufacturing polynucleotides14 Apr 2026US 12,600,958 B2Primrose Bio, Inc.
- Large scale synthesis of messenger RNA14 Apr 2026US 12,600,998 B2Translate Bio, Inc.
- RNase inhibitors24 Feb 2026US 12,559,753 B2New England Biolabs, Inc.
- System, Kit, and Method for Continuous Directed Evolution8 Oct 2026US 2026/0308569 A1The Board of Trustees of the University of Illinois
- Methods and compositions for nucleic acid synthesis24 Sep 2026US 2026/0286415 A1Primrose Bio, Inc.
- Methods of producing rna3 Sep 2026US 2026/0258464 A1ModernaTX, Inc.
- Synthetic mrna encoding hif-1alpha and uses for wound healing20 Aug 2026US 2026/0242778 A1The Johns Hopkins University
- Manufacture of messenger rna with kp34 polymerase13 Aug 2026US 2026/0234683 A1Sanofi Pasteur Limited
Most cited
By later US patents
- Enzymes and polymerases for the synthesis of RNA119US 9,512,456 B2ModernaTX, Inc. · 2016
- Modifications of mammalian cells using artificial micro-RNA to alter their properties and the compositions of their products88US 11,162,102 B2Dna Twopointo Inc. · 2021
- Recombinant negative strand RNA virus expression systems and vaccines47US 6,887,699 B1MedImmune Vaccines, Inc. · 2005
- RNA polymerase variants for co-transcriptional capping42US 11,485,960 B2ModernaTX, Inc. · 2022
- Sample preparation methods, systems and compositions37US 10,697,008 B2Karius, Inc. · 2020